Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
2.78
-0.14 (-4.79%)
At close: Jun 05, 2025, 3:59 PM
2.77
-0.36%
Pre-market: Jun 06, 2025, 04:45 AM EDT
-4.79%
Bid 2.65
Market Cap 299.51M
Revenue (ttm) n/a
Net Income (ttm) -258.03M
EPS (ttm) -2.63
PE Ratio (ttm) -1.06
Forward PE -1.74
Analyst Buy
Ask 2.8
Volume 4,338,963
Avg. Volume (20D) 4,497,501
Open 2.96
Previous Close 2.92
Day's Range 2.73 - 2.96
52-Week Range 2.19 - 26.98
Beta 0.68

About RCKT

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RCKT
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for RCKT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 week ago
-62.84%
Rocket Pharmaceuticals shares are trading lower af... Unlock content with Pro Subscription
3 weeks ago
+11.06%
Rocket Pharmaceuticals shares are trading higher after the company presented preliminary data from its Phase 1 trial of RP-A601.